Max Healthcare expands India footprint with acquisition of Alexis Multi-Speciality hospital 

INDIA -Max Healthcare Institute Ltd has completed the acquisition of 99.9% stake in Alexis Multi-Speciality Hospital Pvt Ltd for an enterprise value of Rs 412 crore (US$49.62 million).  

An Indian for-profit private hospital chain headquartered in Delhi, Max Healthcare owns and operates 17 hospitals with 3500+ beds and 4800+ clinicians across the Delhi National Capital Region, Mohali, Bathinda, Dehradun and Mumbai. 

The acquisition aligns with Max Healthcare’s strategic expansion plans in Western and Central India, aiming to enhance its service offerings and geographical presence. 

 Following the acquisition, Alexis Multi-Speciality Hospital has been rebranded as Max Super Speciality Hospital, Nagpur, reflecting the integration of the two entities. 

Established in 2016, Alexis Hospital has emerged as a premier healthcare facility, providing comprehensive tertiary care services such as organ transplant, oncology, neurology, cardiology, gastroenterology, and diagnostics.  

Max Healthcare Chairman and Managing Director, Abhay Soi, hailed the acquisition as a significant milestone in the company’s growth journey, underscoring its commitment to delivering exceptional healthcare services and value to patients in the region. 

Global investment firms eye acquisition of HCG 

Meanwhile, EQT, TPG Capital, and KKR are reportedly evaluating the acquisition of a controlling stake held by CVC Capital in Healthcare Global Enterprises (HCG), a prominent Bengaluru-based specialty cancer hospital chain.  

The move comes amidst heightened consolidation and increased deal activity in Asia’s healthcare sector, driven by rising demand for private medical services. 

CVC Capital, which currently holds around 60.41% stake in HCG, is exploring a potential sale that could involve an open offer for an additional 26% of the company. 

 The valuation of CVC’s stake in HCG has surged significantly, reflecting the company’s robust growth trajectory and market potential. 

While Ajai Kumar, founder and executive chairman of HCG, reiterated his commitment to the company’s mission of serving cancer patients, EQT, TPG, and KKR are reportedly evaluating the opportunity for a significant investment in HCG. 

HCG, with its extensive network of 22 cancer hospitals and three multispecialty hospitals across India, has positioned itself as a leading player in cancer care treatment. 

The company’s strategic initiatives, including debt reduction, operational efficiency enhancements, and capacity expansion, have bolstered its financial performance and market position 

Analysts believe its dominant presence in cancer care treatment is driven by strong brand equity and superior quality of service along with partnership with other established medical professionals. 

The company also operates seven IVF fertility centres under the brand ‘Milann’ through its wholly owned subsidiary, BACC Healthcare Private Limited (BACC). 

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.